First-line toripalimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma: A cost-effectiveness analysis - Jing-Wen Han; Yu Zhong; Jin Zhong; Wen-Jing Zeng; Li-Jun Sun (PLoS ONE)